Olofi Pharma & Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -67.04%
- Profit Growth -468.33%
- Ebitda -340.92%
- Net Worth -62.83%
- Total Assets -52.99%
About Olofi Pharma & Healthcare
Olofi Pharma & Healthcare Private Limited (OPHPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2010 and has a history of 15 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanand Vemulapalli, Ravindra Goli, Likhitha Vemulapalli, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21001TG2010PTC067079
- Company No.
067079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Olofi Pharma & Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanand Vemulapalli  | Managing Director | 19-Feb-2010 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Goli | Additional Director | 08-Feb-2024 | Current |
| Likhitha Vemulapalli | Director | 23-Mar-2023 | Current |
| Padma Sajja | Additional Director | 08-Feb-2024 | Current |
Financial Performance of Olofi Pharma & Healthcare.
Olofi Pharma & Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 67.04% decrease. The company also saw a substantial fall in profitability, with a 468.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olofi Pharma & Healthcare?
In 2017, Olofi Pharma & Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Olofi Pharma & Healthcare?
Olofi Pharma & Healthcare has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olofi Pharma & Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olofi Pharma & Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
